医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Partnership: joimax® Joins Forces with JAPAN MEDICALNEXT CO., LTD.

2020年06月18日 AM02:32
このエントリーをはてなブックマークに追加


 

KARLSRUHE, Germany

joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting, as of now, a new partnership in Japan. The distributor JMC-JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200617005680/en/

New Partnership: joimax® Joins Forces with JAPAN MEDICALNEXT CO., LTD. (Graphic: Business Wire)

New Partnership: joimax® Joins Forces with JAPAN MEDICALNEXT CO., LTD. (Graphic: Business Wire)

“joimax® is looking forward to working with a partner as strong as JMC,” says joimax® Founder and CEO Wolfgang Ries. “JMC is a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market.” Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan.” Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD., founded in 1992, is located in Osaka, Japan. With 314 employees at its locations, and an Orthopedics Division that will focus on joimax® products, the company is a wholly owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

About joimax®

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for full-endoscopic and minimally invasive spinal surgery. With the Endoscopic Surgical Systems TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® for facet and sacroiliac joint pain treatment, EndoLIF® and Percusys® for minimally invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications.

In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax® technologies to operate through small incisions under local or full anesthesia, via tissue and muscle-sparing corridors and through natural openings in the spinal canal, e.g. the intervertebral foramen, the so-called “Kambin triangle.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20200617005680/en/

CONTACT

Press Contact Germany:

joimax® GmbH

Tatjana Elschnig

Tatjana.Elschnig@joimax.com

0049-721-25514-0

Press Contact USA:

joimax® Inc.

Emily Campbell

emily.campbell@joimaxusa.com

001-949-859-3472

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作